Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

PIGA Gene Early Infantile Epileptic Encephalopathy Type 20 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين PIGA للاعتلال الدماغي الصرعي المبكر من النوع 20 بتقنية التسلسل الجيني من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS with Sanger confirmation.
  • Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection (8 AM – 11 PM) and VIP Mobile Phlebotomy.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance by a DHA-licensed genetic counselor and neurologist to interpret results.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

يقدم هذا الاختبار الجيني المعتمد من هيئة الصحة بدبي أعلى دقة تشخيصية لطفرة جين PIGA بنسبة 99.9%، مع خدمة سحب عينات منزلية فائقة الجودة واستشارة طبية هاتفية بعد النتيجة، بما يضمن أعلى معايير الخصوصية وفق قانون الإمارات لحماية البيانات الشخصية.

UAE COMPLIANCE: This test fully adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors Consent), and UAE Personal Data Protection Law (PDPL). Laboratory ISO 9001:2015 Cert. No. INT/EGQ/2509DA/3139.

Overview

The PIGA gene test detects pathogenic variants causing Early Infantile Epileptic Encephalopathy Type 20 (EIEE20), a severe neurological disorder. Delivered via Next-Generation Sequencing, this test provides a definitive molecular diagnosis enabling tailored antiepileptic therapy and accurate genetic counseling.

فحص جين PIGA يكشف الطفرات المسببة للاعتلال الدماغي الصرعي المبكر النمط 20 بدقة عالية، مما يساعد في توجيه العلاج وتقديم الاستشارة الوراثية.

Feature Our Test (PIGA NGS) Closest Alternative (Whole Exome)
Precision 99.9% diagnostic sensitivity, Sanger verified ~90% for PIGA-specific variants
Methodology Targeted NGS with deep coverage of all exons Broad exome sequencing, lower read depth
Turnaround 3–4 Weeks 4–6 Weeks

Physician Insight & Safety Protocol

“As a neurologist, I understand how overwhelming an EIEE diagnosis can be for families. This genetic test provides the critical clarity needed to guide seizure management and inform future family planning. Please remember that a positive result does not define a child’s future; with early intervention, many children achieve remarkable progress.”

– Dr. Prabhakar Reddy, DHA License No. 61713011, Consultant Neurologist

MEDICATION SAFETY NOTICE

Do not discontinue prescribed medication without consulting your doctor. Abrupt withdrawal from antiepileptics can trigger life-threatening status epilepticus.

Clinical Safety & Exclusion Criteria

  • Exclusion Criteria: Patients without a documented clinical history of infantile epileptic encephalopathy or suspected metabolic disorders must first complete metabolic screening.
  • Emergency Red Flags: If your child experiences a seizure lasting longer than 5 minutes, sudden unresponsiveness, breathing difficulty, or cyanosis, seek immediate emergency medical care.

Patient FAQ & Clinical Guidance

What is the PIGA gene early infantile epileptic encephalopathy type 20 test?

This test sequences the PIGA gene using next-generation technology to identify disease-causing mutations linked to severe infantile epilepsy. The analysis includes all coding exons and flanking regions, delivering a definitive molecular diagnosis. A positive result confirms EIEE20 and guides antiepileptic drug selection, while a negative result rules out this specific condition and directs further investigation.

هذا الفحص الجيني يُحلل تسلسل جين PIGA باستخدام تقنية الجيل التالي لتحديد الطفرات المسببة للصرع الرضيعي الشديد، مما يساعد في توجيه العلاج بدقة.

How is the test performed, and does it require a blood draw?

A simple blood sample, extracted DNA, or a single drop of blood on an FTA card is collected via VIP home phlebotomy service, requiring no special preparation beyond providing a clinical history. Our mobile team arrives at your doorstep with cold-chain transport, and the sample is processed in our ISO-certified lab. The procedure is painless and completed within minutes, even for infants.

يتم سحب عينة بسيطة من الدم أو استخدام نقطة دم على بطاقة خاصة في المنزل عبر فريق تمريض متنقل دون الحاجة لتجهيزات معقدة، وتُجرى بسلامة تامة للأطفال الرضع.

When will I receive results, and how will they be explained?

Results are delivered in 3–4 weeks, with a mandatory telephonic post- counselling session by a board-certified geneticist. The comprehensive report includes variant interpretation, clinical correlation, and recommendations for family screening. We ensure you understand the implications before and after testing, aligning with DHA guidelines for genetic testing.

تصدر النتائج خلال 3-4 أسابيع يليها جلسة استشارة هاتفية من أخصائي وراثة معتمد لتفسير التقرير وتقديم التوصيات العائلية.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians